Biotechnology Research
Found 1 companies.
🏢 Amgen
💰 $28.5B Post-IPO Debt on 2022-12-12🫂 on 2023-10-24Biotechnology Research
Website LinkedIn Email Phone # Facebook Twitter

Amgen is a biotechnology company that specializes in developing and manufacturing human therapeutics for a wide range of diseases. They are committed to using science and innovation to create transformative medicines for patients with serious illnesses.